Amicus Therapeutics announces EC approval for Pombiliti™
Congratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset...
read Details
Incyte announces FDA approval for Zynyz™
Incyte announces FDA approval for Zynyz™
Congratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC). Modality Solutions is proud to have been a part of its cold chain strategy!
Stay on top of the industry trends
You may also like
Acadia Pharmaceuticals, Inc. announces FDA Approval of Daybue
The team at Acadia Pharmaceuticals Inc. announced FDA Approval on their drug Daybue, for...
read Details
Atara Biotherapeutics Announces EU Approval
The team at Atara Biotherapeutics announced EU Approval on their allogeneic T-cell therapy to treat adult...
read Details